|
|
| (11) | Number of the document | |
| (68) | Number of the document | 2680873 |
| (21) | Application number for Supplementary Protection Certificate | PA 2024 520 |
| (22) | Date of filing the application | 2024-06-19 |
| (41) | Date of publication of the application | 2024-07-10 |
| Date of publication of SPC | ||
| (24) | Date of coming into effect of SPC |
| (71) |
Napp Pharmaceutical Group Limited,
Unit 191 Cambridge Science Park, Milton Road, Cambridge,
GB
|
| (73) |
Napp Pharmaceutical Group Limited,
Unit 191 Cambridge Science Park, Milton Road, Cambridge,
GB
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/23/1775, 2023-12-22 |
| (95) | Rezafunginas arba farmaciniu požiūriu priimtina jo druska, ypač rezafungino acetatas |
| SPC application published |